January 31, 2018
Wayne, PA – CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions for clinical trials, has been honoured in this year’s Biotechnology Awards with the CluePoints® solution being named the “Best Risk-Based Monitoring Solution”.
The Biotechnology Awards recognize the key players and companies that are driving the industry forward with game-changing advances and revolutionary developments. It celebrates the products, services, and solutions carried out around the world over the previous 12 months, selected by an international judging panel of individuals from a myriad of fields such as business, media, and journalism.
CluePoints’ ability to listen to the needs of the industry was a key factor in the company’s successful entry. A prime example is the annual User Group Meeting conducted in April, where clients are invited to discuss their thoughts and ideas. This empowers customers to play a key part in both shaping the future of the CluePoints solution as well as continuing to innovate and deliver new products and enhancements that will drive compliance, accelerate drug development, improve data quality and achieve cost and resource efficiencies.
“CluePoints’ expertise in providing software to enable Risk-Based Monitoring and improve data quality is unparalleled. Being named the “Best Risk-Based Monitoring Solution” in this year’s Biotechnology Awards is great validation for the exceptional work performed by all our staff and the partnerships we have developed with our clients over the last 5 years,” commented Patrick Hughes, Chief Commercial Officer at CluePoints. “We are honoured that the judges recognize CluePoints as being among the best in the industry.”
“CluePoints, as a company, has proven themselves to be leaders in reducing the risk associated with sponsors’ regulatory submissions” commented the leader of the awards judging panel. “A relatively young company in the biopharmaceuticals field, CluePoints has made a positive impact in the field of clinical investigations oversight. For all it has accomplished in such a short time, the judging panel found this to be a best-in-class services provider.”
For further information on CluePoints’ solutions, please visit www.cluepoints.com
CluePoints® is a Risk-Based Monitoring and Central Statistical Monitoring solution that has been designed and perfected over the last 15 years. It employs unique statistical algorithms to determine the quality, accuracy, and integrity of clinical trial data both during and after study conduct. Aligned with guidance from the ICH, FDA, and EMA, CluePoints® is deployed to support traditional on-site monitoring, medical review and to drive a Risk-Based Monitoring strategy. The value of using CluePoints® lies in its powerful and timely ability to identify anomalous data and site errors allowing improvement in clinical data quality, optimization of on-site monitoring and a significant reduction in overall regulatory submission risk.
Patrick Hughes – Chief Commercial Officer, CluePoints
+44 (0) 7703 532 749